Choate Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Choate Investment Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$214K	Buy
2024 Q2	–	Sell
2024 Q1	$249K	Hold
2023 Q4	$229K	Buy
2021 Q3	–	Sell
2021 Q2	$276K	Buy